@article{article, title  = {{Adalimumab for Treating Moderate-to-Severe Hidradenitis Suppurativa: An Evidence Review Group Perspective of a NICE Single Technology Appraisal}},

 url = {{http://eprints.whiterose.ac.uk/114278/ }},

 year = {{2017}},

 month = {{8}},

 author = {{Tappenden P and Carroll C and Stevens JW and Rawdin A and Grimm S and Clowes M and Kaltenthaler E and Ingram JR and Collier F and Ghazavi M}},

 doi = {{10.1007/s40273-017-0488-2}},

 volume = {{35}},

 journal = {{PharmacoEconomics}},

 issue = {{8}},

 pages = {{805-815}},

 note = {{Accessed on 2024/12/22}}}